Pipex/AEN has had a history with University of Michigan (I think they got a compound or two from them)...I think its more of a bad light of University of Michigan then doubt its Kanzer :-).
BTW, thanks for posting the transcript almost as funny as the pic :-).
They did redo the trial, data should be available this year I believe. Dor did the name change to Soligenix SNGX.
Considering the same basic steroid product is now being compounded and used by transplant centers for the same indication, one would think the trial has a good chance of working.
Market Data 
Markets 
AI
